1875.HK Stock Analysis
18
Uncovered
TOT BIOPHARM International Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
TOT BIOPHARM International Co. Ltd. is clinical stage biopharmaceutical company, which engages in developing and commercializing oncology drugs and therapies. The company is headquartered in Suzhou, Jiangsu and currently employs 355 full-time employees. The company went IPO on 2019-11-08. The firm has a portfolio of oncology drug candidates, which include monoclonal antibodies (mAbs), antibody drug conjugates (ADCs), oncolytic virus products and specialty oncology drugs such as liposome drugs.